F-group (family)
188.1.1.1 Hormone_recep
Ligands and drugs
4,159
Member domains
3,080
with ligand contacts (≤ 4 Å)
74.1% of members
2,818
with DrugDomain annotations
67.8% of members
1,278
with a DrugBank compound
30.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 188.1.1.1 belongs to X-group 188 Nuclear receptor ligand-binding domain, which binds 11.4 ligand superclasses per 20 proteins, broader than 99% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00783 | EST | Estradiol | 64 |
| DB03338 | B7G | Heptyl glucoside | 57 |
| DB02901 | DHT | Stanolone | 52 |
| DB04468 | OHT | Afimoxifene | 38 |
| DB00523 | 9CR | Alitretinoin | 37 |
| DB04349 | PGO | (S)-propane-1,2-diol | 35 |
| DB01234 | DEX | Dexamethasone | 29 |
| DB00755 | REA | Tretinoin | 22 |
| DB00412 | BRL | Rosiglitazone | 21 |
| DB07080 | 444 | TO-901317 | 20 |
| DB03047 | EPH | L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine | 19 |
| DB00136 | VDX | Calcitriol | 17 |
| DB07863 | GW9 | 2-chloro-5-nitro-N-phenylbenzamide | 17 |
| DB00255 | DES | Diethylstilbestrol | 14 |
| DB00481 | RAL | Raloxifene | 14 |
| DB03604 | 4HY | Tiratricol | 14 |
| DB00279 | T3 | Liothyronine | 13 |
| DB00396 | STR | Progesterone | 13 |
| DB00421 | SNL | Spironolactone | 13 |
| DB00624 | TES | Testosterone | 13 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| EST | ESTRADIOL | 66 |
| CL | CHLORIDE ION | 60 |
| B7G | heptyl beta-D-glucopyranoside | 57 |
| DHT | 5-ALPHA-DIHYDROTESTOSTERONE | 51 |
| DEX | DEXAMETHASONE | 46 |
| OHT | 4-HYDROXYTAMOXIFEN | 36 |
| PGO | S-1,2-PROPANEDIOL | 35 |
| NAmetal | SODIUM ION | 33 |
| 9CR | (9cis)-retinoic acid | 30 |
| GW9 | 2-chloro-5-nitro-N-phenylbenzamide | 22 |
| 444 | N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE | 19 |
| EPH | L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE | 19 |
| EDK | (2~{S})-3-[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]-2-[[2-(phenylcarbonyl)phenyl]amino]propanoic acid | 18 |
| REA | RETINOIC ACID | 18 |
| CPS | 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE | 17 |
| VDX | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL | 17 |
| BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2-(METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]-(9CL) | 16 |
| Kmetal | POTASSIUM ION | 16 |
| KNA | nonanoic acid | 15 |
| 4HY | [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID | 14 |